All News
Medical Xpress / Visual analog scale has comparable validity for perennial allergic, nonallergic rhinitis
The visual analog scale (VAS) demonstrates comparable validity for perennial allergic rhinitis (PAR) and nonallergic rhinitis (NAR) severity and quality-of-life (QoL) impairment, according to a study published online Dec. ...
Medical Xpress / Nine easy New Year's resolutions for people over 50
If you're over 50, you've probably made, and perhaps broken, a lot of New Year's resolutions by now.
Phys.org / Scientists outline how to control light at the atomic scale using polaritons
Controlling light at dimensions thousands of times smaller than the thickness of a human hair is one of the pillars of modern nanotechnology.
Phys.org / Video: Fly through Webb's cosmic vistas
On the launch anniversary of the NASA/ESA/CSA James Webb Space Telescope, ESA presents a unique compilation of zooms into stunning cosmic views.
Medical Xpress / FDA approves Jascayd for progressive pulmonary fibrosis
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults.
Medical Xpress / Exploring the occurrence of coal workers' pneumoconiosis-linked deaths
From 2020 to 2023, 1,754 decedents had coal workers' pneumoconiosis (CWP) listed on their death certificates, according to research published in the Dec. 18 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...
Medical Xpress / Understanding childhood obesity: Causes, treatments and how to reduce stigma
While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.
Medical Xpress / Prescribing of some controlled medications has decreased in youth over past two decades
In the past two decades, there were decreases in prescribing of some controlled medications to adolescents and young adults, according to a study published online Dec. 15 in Drug and Alcohol Dependence.
Medical Xpress / Tirzepatide noninferior to dulaglutide for CV outcomes in type 2 diabetes
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, according ...
Phys.org / AI-driven breeding strategy aims to boost orphan crops for food security
With global population growth and climate change posing escalating threats to crop production, the current food system is unlikely to be sufficient to meet future demand. Although more than 12,000 plant species are edible, ...
Phys.org / Dual-cation strategy boosts upconversion efficiency in stable oxide perovskites
Researchers at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences have developed a new way to significantly enhance upconversion luminescence in oxide perovskites, a class of materials known for their ...
Tech Xplore / Two-way electric vehicle charging at scale could stop renewable energy being wasted—here's how it works
The amount of renewable energy produced around the world is increasingly exceeding demand—particularly from wind and solar sources. This presents a significant challenge when limited grid capacity and insufficient energy ...
